Becton Dickinson and Company 

$48.16
6
+$0.66+1.39% Wednesday 20:00

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
13.69B
本益比
0
股息殖利率
-
股息
-

即將到來

股息

0%股息殖利率
Sep 25
$0.75
Jun 25
$0.75
Mar 25
$0.75
Dec 24
$0.75
Sep 24
$0.75
10年成長
不適用
5年成長
不適用
3年成長
13.43%
1年成長
-25%

財報

30Apr預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
2.21
2.79
3.38
3.96
預期EPS
2.775
實際EPS
不適用

財務

8.95%利潤率
有盈利
2017
2018
2019
2020
2021
2022
18.87B營收
1.69B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 BDXB 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. It has a strategic partnership with the Biomedical Advanced Research and Development Authority to develop new manufacturing lines for injection devices. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Show more...
執行長
Thomas Polen
員工
70000
國家
US
ISIN
US0758874061

上市

0 Comments

分享你的想法

FAQ

Becton Dickinson and Company 今天的股價是多少?
BDXB 目前價格為 $48.16 USD,過去 24 小時上漲了 +1.39%。在圖表上更密切關注 Becton Dickinson and Company 股價表現。
Becton Dickinson and Company 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Becton Dickinson and Company 的股票以代號 BDXB 進行交易。
Becton Dickinson and Company 的市值是多少?
今天 Becton Dickinson and Company 的市值為 13.69B
Becton Dickinson and Company 去年的營收是多少?
Becton Dickinson and Company 去年的營收為 18.87BUSD。
Becton Dickinson and Company 去年的淨利是多少?
BDXB 去年的淨收益為 1.69BUSD。
Becton Dickinson and Company 會發放股息嗎?
是的,BDXB 的股息每 每季 發放一次。每股最新股息為 0.75 USD。截至今日,股息殖利率(FWD)% 為 0%。
Becton Dickinson and Company 有多少名員工?
截至 April 02, 2026,公司共有 70,000 名員工。
Becton Dickinson and Company 位於哪個產業?
Becton Dickinson and Company從事於Manufacturing產業。
Becton Dickinson and Company 何時完成拆股?
Becton Dickinson and Company 最近沒有進行任何拆股。
Becton Dickinson and Company 的總部在哪裡?
Becton Dickinson and Company 的總部位於 US 的 Franklin Lakes。